Advice
In the absence of a submission from the holder of the marketing authorisation:
prednisone (Lodotra®) is not recommended for use within NHS Scotland.
Indication under review: treatment of moderate to severe, active rheumatoid arthritis in adults particularly when accompanied by morning stiffness.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice38KB (PDF)
Medicine details
- Medicine name:
- prednisone MR (Lodotra)
- SMC ID:
- 771/12
- Indication:
- Rheumatoid arthritis
- Pharmaceutical company
- Napp Pharmaceuticals Ltd
- BNF chapter
- Endocrine system
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 13 February 2012